Skip to main content
SpringerLink
Log in

NICE draft guidance recommends peginterferon-α . . .

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NICE. NICE draft guidance recommends drugs to treat chronic hepatitis C in children and young people. Media Release : 17 Jul 2013. Available from: URL: http://www.nice.org.uk.

  2. NICE. NICE consults on a new treatment for myelodysplastic syndromes. Media Release : 11 Jul 2013. Available from: URL: http://www.nice.org.uk.

  3. NICE. NICE consults on a new treatment for chronic myeloid leukaemia. Media Release : 16 Jul 2013. Available from: URL: http://www.nice.org.uk.

  4. NICE. NICE consults on treatment for rare autoimmune disease and asks for further information from the manufacturer. Media Release : 22 Jul 2013. Available from: URL: http://www.nice.org.uk.

  5. NICE. NICE guidance supports new device for assessing a pregnancy complication which affects thousands of women. Media Release : 17 Jul 2013. Available from: URL: http://www.nice.org.uk.

  6. NICE. NICE guidance supports use of a device to visualise the airway in emergencies and improve patient safety. Media Release : 17 Jul 2013. Available from: URL: http://www.nice.org.uk.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE draft guidance recommends peginterferon-α . . .. PharmacoEcon Outcomes News 683, 11 (2013). https://doi.org/10.1007/s40274-013-0587-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0587-z

Search

Navigation